313 related articles for article (PubMed ID: 7645210)
21. Characterization of the upstream enhancer of the rat sodium/iodide symporter gene.
Chun JT; Di Lauro R
Exp Clin Endocrinol Diabetes; 2001; 109(1):23-6. PubMed ID: 11573134
[TBL] [Abstract][Full Text] [Related]
22. Transcriptional repression of the alpha 1(I) collagen gene by ras is mediated in part by an intronic AP1 site.
Slack JL; Parker MI; Bornstein P
J Cell Biochem; 1995 Jul; 58(3):380-92. PubMed ID: 7593259
[TBL] [Abstract][Full Text] [Related]
23. Delineation of human papillomavirus type 18 enhancer binding proteins: the intracellular distribution of a novel octamer binding protein p92 is cell cycle regulated.
Royer HD; Freyaldenhoven MP; Napierski I; Spitkovsky DD; Bauknecht T; Dathan N
Nucleic Acids Res; 1991 May; 19(9):2363-71. PubMed ID: 1645869
[TBL] [Abstract][Full Text] [Related]
24. An inducible enhancer controls the expression of the human interleukin 1 beta gene.
Bensi G; Mora M; Raugei G; Buonamassa DT; Rossini M; Melli M
Cell Growth Differ; 1990 Oct; 1(10):491-7. PubMed ID: 2278879
[TBL] [Abstract][Full Text] [Related]
25. Nuclear matrix attachment regions of human papillomavirus type 16 repress or activate the E6 promoter, depending on the physical state of the viral DNA.
Stünkel W; Huang Z; Tan SH; O'Connor MJ; Bernard HU
J Virol; 2000 Mar; 74(6):2489-501. PubMed ID: 10684263
[TBL] [Abstract][Full Text] [Related]
26. The 5' region of the human papillomavirus type 31 upstream regulatory region acts as an enhancer which augments viral early expression through the action of YY1.
Kanaya T; Kyo S; Laimins LA
Virology; 1997 Oct; 237(1):159-69. PubMed ID: 9344918
[TBL] [Abstract][Full Text] [Related]
27. Enhancer binding factors AP-4 and AP-1 act in concert to activate SV40 late transcription in vitro.
Mermod N; Williams TJ; Tjian R
Nature; 1988 Apr; 332(6164):557-61. PubMed ID: 2833704
[TBL] [Abstract][Full Text] [Related]
28. Constitutive and steroid hormone regulated transcriptional enhancer elements in the genome of the human papilloma virus type 16, which is associated with neoplasia of the cervix.
Klock G; Gloss B; Bernard HU
Cancer Detect Prev; 1988; 12(1-6):23-9. PubMed ID: 2846169
[TBL] [Abstract][Full Text] [Related]
29. Transcription factor AP1 modulates the internal promoter activity of bovine foamy virus.
Wu Y; Tan J; Su Y; Qiao W; Geng Y; Chen Q
Virus Res; 2010 Jan; 147(1):139-44. PubMed ID: 19853631
[TBL] [Abstract][Full Text] [Related]
30. Differential regulation by c-jun and c-fos protooncogenes of hormone response from composite glucocorticoid response element in human papilloma virus type 16 regulatory region.
Mittal R; Kumar KU; Pater A; Pater MM
Mol Endocrinol; 1994 Dec; 8(12):1701-8. PubMed ID: 7708058
[TBL] [Abstract][Full Text] [Related]
31. Transcription of the transforming genes of the oncogenic human papillomavirus-16 is stimulated by tumor promotors through AP1 binding sites.
Chan WK; Chong T; Bernard HU; Klock G
Nucleic Acids Res; 1990 Feb; 18(4):763-9. PubMed ID: 2156229
[TBL] [Abstract][Full Text] [Related]
32. A factor discriminating between the wild-type and a mutant polyomavirus enhancer.
Kovesdi I; Satake M; Furukawa K; Reichel R; Ito Y; Nevins JR
Nature; 1987 Jul 2-8; 328(6125):87-9. PubMed ID: 3037380
[TBL] [Abstract][Full Text] [Related]
33. Methylation sensitivity of the enhancer from the human papillomavirus type 16.
List HJ; Patzel V; Zeidler U; Schopen A; Rühl G; Stollwerk J; Klock G
J Biol Chem; 1994 Apr; 269(16):11902-11. PubMed ID: 8163489
[TBL] [Abstract][Full Text] [Related]
34. trans activation by the full-length E2 proteins of human papillomavirus type 16 and bovine papillomavirus type 1 in vitro and in vivo: cooperation with activation domains of cellular transcription factors.
Ushikai M; Lace MJ; Yamakawa Y; Kono M; Anson J; Ishiji T; Parkkinen S; Wicker N; Valentine ME; Davidson I
J Virol; 1994 Oct; 68(10):6655-66. PubMed ID: 8083999
[TBL] [Abstract][Full Text] [Related]
35. A splicing enhancer in the E4 coding region of human papillomavirus type 16 is required for early mRNA splicing and polyadenylation as well as inhibition of premature late gene expression.
Rush M; Zhao X; Schwartz S
J Virol; 2005 Sep; 79(18):12002-15. PubMed ID: 16140776
[TBL] [Abstract][Full Text] [Related]
36. Identification of cis-regulatory elements in the upstream regulatory region of human papillomavirus type 59.
Rho J; Lee S; de Villiers EM; Choe J
Virus Res; 1997 Feb; 47(2):155-66. PubMed ID: 9085547
[TBL] [Abstract][Full Text] [Related]
37. Characterization of a nuclear factor, papilloma enhancer binding factor-1, that binds the long control region of human papillomavirus type 16 and contributes to enhancer activity.
Cuthill S; Sibbet GJ; Campo MS
Mol Carcinog; 1993; 8(2):96-104. PubMed ID: 8397799
[TBL] [Abstract][Full Text] [Related]
38. NF-IL6 represses early gene expression of human papillomavirus type 16 through binding to the noncoding region.
Kyo S; Inoue M; Nishio Y; Nakanishi K; Akira S; Inoue H; Yutsudo M; Tanizawa O; Hakura A
J Virol; 1993 Feb; 67(2):1058-66. PubMed ID: 8380454
[TBL] [Abstract][Full Text] [Related]
39. An element binding a C/EBP-related transcription factor contributes to negative regulation of the bovine papillomavirus type 4 long control region.
McCaffery RE; Jackson ME
J Gen Virol; 1994 Nov; 75 ( Pt 11)():3047-56. PubMed ID: 7964614
[TBL] [Abstract][Full Text] [Related]
40. Clusters of nuclear factor I binding sites identify enhancers of several papillomaviruses but alone are not sufficient for enhancer function.
Gloss B; Yeo-Gloss M; Meisterenst M; Rogge L; Winnacker EL; Bernard HU
Nucleic Acids Res; 1989 May; 17(9):3519-33. PubMed ID: 2542901
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
